Covid-Associated Mucormycosis (CAM)


Since the onset of the COVID 19 pandemic there have been multiple reports across India and neighbor countries of very high incidence of mucormycosis among patients with COVID 19 especially in those who are diabetic and those who have received steroids.
Covid-associated mucormycosis (CAM) has been associated with high morbidity and mortality, exorbitant treatment costs and has led to shortage of antifungal drugs.

For all info, please click below
FISF recommendation mucormycosis

Link to the videos: (8) IDIM – Mucormycosis – YouTube

< back